Metabolic Profiling in Maturity-Onset Diabetes of the Young (MODY) and Young Onset Type 2 Diabetes Fails to Detect Robust Urinary Biomarkers

It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Gloyn, Anna L., Faber, Johan H., Malmodin, Daniel, Thanabalasingham, Gaya, Lam, Francis, Ueland, Per Magne, McCarthy, Mark I., Owen, Katharine R., Baunsgaard, Dorrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408469/
https://www.ncbi.nlm.nih.gov/pubmed/22859960
http://dx.doi.org/10.1371/journal.pone.0040962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408469/
https://www.ncbi.nlm.nih.gov/pubmed/22859960
http://dx.doi.org/10.1371/journal.pone.0040962

Ejemplares similares